Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001706176-26-000002
Filing Date
2026-01-06
Accepted
2026-01-06 16:21:45
Documents
1
Period of Report
2026-01-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1767734500.html 4  
1 FORM 4 wk-form4_1767734500.xml 4 7121
  Complete submission text file 0001706176-26-000002.txt   8811
Mailing Address C/O REGULUS THERAPEUTICS INC. 10614 SCIENCE CENTER DRIVE SAN DIEGO CA 92121
Business Address
Chevallard Daniel R. (Reporting) CIK: 0001706176 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40532 | Film No.: 26511855

Mailing Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075
Business Address 201 LOMAS SANTA FE DRIVE, SUITE 300 SOLANA BEACH CA 92075 858-925-7000
LENZ Therapeutics, Inc. (Issuer) CIK: 0001815776 (see all company filings)

EIN.: 844867570 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)